Thiogenesis Therapeutics, Corp. (TSXV:TTI)
0.7100
+0.0100 (1.43%)
Oct 1, 2025, 10:29 AM EDT
Thiogenesis Therapeutics Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Source: S&P Global Market Intelligence. Standard template. Financial Sources.